查看購物車
  • Simplified Chinese
  • English
  • Japanese
對乙醯氨基酚市場規模及預測（2021-2031年），全球及區域佔有率、趨勢和成長機會分析報告涵蓋範圍：按劑型、適應症、給藥途徑、配銷通路和地理分類
市場調查報告書
商品編碼
1858560

對乙醯氨基酚市場規模及預測（2021-2031年），全球及區域佔有率、趨勢和成長機會分析報告涵蓋範圍：按劑型、適應症、給藥途徑、配銷通路和地理分類

Paracetamol Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Dosage Form, Indication, Route Of Administration, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 244 Pages | 訂單完成後即時交付

價格

預計到2031年，乙醯胺酚市場規模將從2024年的107.4億美元成長至150.2億美元。該市場在2025年至2031年期間的複合年成長率（CAGR）預計為5.0%。推動市場成長的主要因素包括慢性疼痛和發燒相關疾病盛行率的上升，以及乙醯胺酚作為非處方鎮痛藥和退燒藥的廣泛應用。此外，乙醯胺酚複方製劑的推廣也可能在預測期內促進市場成長。然而，原料供應依賴性和價格波動是市場成長的阻礙因素。

慢性疼痛日益被認為是全球嚴峻且不斷擴大的公共衛生挑戰。目前，全球約有五分之一的成年人受到慢性疼痛的困擾，相當於超過15億人。波士頓大學公共衛生學院報告稱，不同地區的慢性疼痛盛行率估計值差異很大，從8%到超過40%不等，具體數值取決於年齡、社會經濟地位以及所使用的定義等因素。例如，根據PubMed Central報告，印度一項社區研究估計，約有19.3%的成年人患有慢性疼痛，約1.8億至2億人；而先前的調查顯示，某些地區的盛行率甚至更高。慢性肌肉骨骼疾病，包括腰痛和頸痛，以及頭痛疾病（尤其是緊張型頭痛和偏頭痛），是造成疼痛的主要原因。全球疾病負擔資料顯示，2019年全球頭痛疾病和肌肉骨骼疾病病例超過26億例。 2009年至2021年間，全球自述疼痛盛行率從26.3%上升至32.1%，全球新增5億疼痛患者，其中女性、年輕成年人、教育程度最低的人群和經濟弱勢群體疼痛盛行率的成長更為迅速。

傷寒等腸熱症在發燒疾病中仍然十分常見，尤其是在南亞地區。 2021年，全球約有107,500人死於傷寒，其中南亞地區約佔三分之二；光是印度一國就佔了全球死亡人數的近一半（約51,500人）。雖然自2017年以來，傷寒死亡率略有下降，但其持續高發病率仍推高了對退燒藥和止痛藥的需求。環境和社會因素——例如城市化、人口老化、久坐的生活方式、不良的人體工學設計、精神壓力和氣候變遷——也給醫療系統帶來了沉重負擔，因為它們增加了疼痛和發熱性疾病（例如登革熱和水傳播疾病）的發病率，而這些疾病的發生率正因病媒擴大和氣候條件變化而不斷上升。

這些相互交織的趨勢——慢性疼痛和發燒患者人數不斷增加、治療不足持續存在、醫療資源分配不均以及加速這兩種疾病發展的結構性因素——正在推動非處方解熱鎮痛藥（如乙醯胺酚）的持續成長。由於慢性疼痛患者在缺乏專科治療的情況下往往依賴非處方藥緩解疼痛，而發燒症狀通常需要立即進行症狀治療，因此乙醯胺酚仍然是一種一線、低成本且易於獲取的選擇。生產商的應對措施包括擴大產品供應範圍、強調安全性宣傳以及將乙醯胺酚納入更多種類的聯合療法中。

本報告透過對乙醯胺酚市場進行比較分析，並根據產品組合（產品滿意度、產品特性和供應情況）、近期市場發展（併購、新產品上市及改進、投資及融資、獎項、協議、合作與夥伴關係、認可和擴張）以及地域分佈情況對市場進行評估和分類，從而幫助企業更好地進行決策並了解競爭格局。報告深入探討了全球乙醯胺酚市場領先供應商近期取得的重大進展和創新。主要市場參與者包括：Mallinckrodt Plc、GSK Plc、強生公司、賽諾菲公司、梯瓦製藥工業有限公司、太陽製藥工業有限公司、西普拉有限公司、瑞迪博士實驗室有限公司、Granules India Ltd 和 IOL Chemicals and Pharmaceuticals Ltd。

根據劑型，乙醯胺酚市場可分為片劑、膠囊和其他劑型。 2024年，片劑佔據了乙醯胺酚市場的大部分佔有率。

依適應症分類，對乙醯氨基酚市場可分為輕度至中度疼痛、發燒和其他。 2024年，輕度至中度疼痛細分市場佔據了對乙醯氨基酚市場的最大佔有率。對乙醯氨基酚仍然是全球推薦的第一線治療藥物，用於治療輕度至中度疼痛，包括頭痛、肌肉酸痛、經痛、牙痛和術後疼痛。其受歡迎的原因在於其中樞性鎮痛機制、胃腸道副作用少以及長期以來無需處方即可購買。這些特性使其適用於包括老年人、孕婦和兒童在內的廣泛人群。臨床證據表明，每四小時服用500毫克至1克（每日最大劑量4克）的劑量可有效緩解許多急性疼痛發作。近期安全文獻，如英國《太陽報》版的一篇媒體報道（2024年），持續質疑老年人群常規使用乙醯胺酚的安全性，指出長期使用會增加多種風險，包括65歲及以上成年人消化性潰瘍出血（+24%）、下消化道出血（+36%）和心臟衰竭風險（+9%），引發了人們對長期高藥的擔憂。新冠疫情期間，乙醯胺酚的使用模式發生了顯著變化，需求激增——許多國家因發燒和全身疼痛而自行用藥的情況激增數倍，鞏固了乙醯胺酚作為常用鎮痛藥的地位。在全球範圍內，慢性疼痛疾病（如頭痛、關節炎、背痛和偏頭痛）負擔的加重推動了乙醯胺酚的持續高使用量，而北美、亞太和拉丁美洲等市場的自行用藥和不斷擴展的電子藥房模式進一步擴大了非處方乙醯胺酚的獲取途徑。

根據給藥途徑，對乙醯氨基酚市場可分為腸內給藥和腸外給藥。由於腸內給藥途徑在疾病治療中被更廣泛接受，預計到2024年，腸內給藥途徑將佔據最大的市場佔有率。

就配銷通路而言，乙醯胺酚市場可分為零售藥局、醫院藥局和線上藥局。由於患者對零售藥局取得藥物的高度依賴，預計到2024年，零售藥局將佔據乙醯胺酚市場最大的佔有率。

在乙醯胺酚市場營運的公司採用多種有機成長和無機成長策略。有機成長策略主要包括產品上市和產品核准。市場上的無機成長策略包括收購、合作和夥伴關係。這些成長策略使市場參與者能夠拓展業務、增強地域覆蓋，並為整體市場成長做出貢獻。此外，收購和夥伴關係還有助於鞏固客戶基礎並擴展產品組合。以下列舉了乙醯胺酚市場主要參與者的一些重要發展動態。

2025年8月，梯瓦製藥工業公司宣布將停止在以色列生產其廣受歡迎的止痛藥Acamol，並將生產轉移至位於德國烏爾姆的工廠。該公司表示，將位於卡法薩巴、擁有約1000名員工的工廠的生產轉移，是其更廣泛的全球戰略的一部分，旨在精簡營運並使以色列產品符合歐洲標準。 Acamol Focus、Acamol Cold（膠囊劑型）和Acamol Forte等其他劑型將繼續在以色列生產。

2024年10月，賽諾菲宣布已與CD&R就出售其消費者保健業務Opella 50%的控股權進行談判。任何協議均需完成必要的社會程序方可達成。關於Opella潛在分拆事宜的進一步消息將在做出決定後公佈。

2024年10月，CFAO收購了Opella Healthcare South Africa。此次合作僅涉及賽諾菲的消費者保健品牌。賽諾菲的藥品和疫苗業務在南非仍將獨立運作。

目錄

第1章：引言

第2章：執行概要

  • 分析師市場展望
  • 市場吸引力

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基礎數字：
    • 數據三角測量：
    • 國家層面資料：
  • 假設和局限性

第4章：乙醯胺酚市場概況

  • 概述
  • PEST分析

第5章：乙醯胺酚市場－主要市場動態

  • 對乙醯氨基酚市場－主要市場動態
  • 主要市場促進因素
    • 慢性疼痛和發燒相關疾病盛行率上升
    • 對乙醯氨基酚作為非處方鎮痛藥和解熱藥的廣泛應用
  • 主要市場限制因素
    • 原物料供應依賴性和價格波動
  • 主要市場機遇
    • 臨床環境中對靜脈注射（IV）對乙醯氨基酚的需求不斷成長
  • 未來主要趨勢
    • 對乙醯氨基酚複方製劑產品範圍擴大
  • 駕駛員和安全帶的影響：

第6章：乙醯胺酚市場－全球市場分析

  • 2021-2031年乙醯胺酚市場收入
  • 對乙醯氨基酚市場預測分析

第7章：乙醯胺酚市場分析－依劑型分類

  • 藥片
  • 膠囊
  • 其他

第8章：乙醯胺酚市場分析－依適應症分類

  • 輕度至中度疼痛
  • 發燒
  • 其他

第9章：乙醯胺酚市場分析－依給藥途徑

  • 腸內營養
  • 腸外

第10章：乙醯胺酚市場分析－依配銷通路分類

  • 零售藥局
  • 醫院藥房
  • 網路藥局

第11章：乙醯胺酚市場－地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第12章：競爭格局

  • 關鍵參與者熱力圖分析
  • 公司定位與集中度

第13章：行業概況

  • 概述
  • 擴張及其他策略發展

第14章：公司簡介

  • Mallinckrodt Plc
  • GSK Plc
  • Johnson & Johnson
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Cipla Ltd
  • Dr. Reddy's Laboratories Ltd
  • Granules India Ltd
  • IOL Chemicals and Pharmaceuticals Ltd.

第15章：附錄

Product Code: TIPRE00038952

The paracetamol market is projected to reach US$15.02 billion by 2031 from US$10.74 billion in 2024. The market is estimated to register a CAGR of 5.0% during 2025-2031. Major factors driving the market growth include a rise in prevalence of chronic pain and fever-related disorders and the wide usage of paracetamol as an over-the-counter (OTC) analgesic and antipyretic are propelling the adoption of paracetamol. Further, expansion of paracetamol combination therapy products will likely boost the market during the forecast period. However, the raw material supply dependency and price volatility are among the market deterrents.

Chronic pain is increasingly recognized as a profound and expanding public health challenge worldwide. It now affects roughly one in five adults globally-equivalent to more than 1.5 billion people. Prevalence estimates vary widely across regions, ranging from 8% to over 40%, depending on factors such as age, socio-economic status, and the definitions used, as reported by the Boston University School of Public Health. In India, for example, a community study estimated that about 19.3% of adults suffer chronic pain, roughly 180-200 million individuals, with previous surveys suggesting even higher rates in some regions, as per the PubMed Central. Chronic musculoskeletal disorders, including low back pain and neck pain, and headache disorders (notably tension-type headache and migraine), are the predominant contributors, with Global Burden of Disease data reporting over 2.6 billion cases of headache disorders and musculoskeletal disorders in 2019. Between 2009 and 2021, global self-reported pain prevalence rose from 26.3% to 32.1%, adding half a billion additional pain sufferers worldwide, with more rapid increases seen among women, younger adults, the least educated, and economically disadvantaged groups.

Conditions such as enteric fever (typhoid) remain prevalent on the fever-related disorders side, particularly in South Asia. In 2021, there were ~107,500 deaths globally attributed to enteric fever, with South Asia accounting for roughly two-thirds of those fatalities; India alone represented nearly half of global deaths (~51,500 deaths). While enteric fever mortality has slightly declined since 2017, the residual high incidence continues to drive the demand for antipyretic and analgesic treatments. Environmental and social determinants-such as urbanization, aging populations, sedentary lifestyles, poor ergonomics, mental stress, and climate change-are also taxing health systems by raising the incidence of both pain and fever-triggering infections such as dengue and waterborne diseases, whose frequencies are increasing due to expanding vector ranges and changing climatic conditions.

These intersecting trends-a rising population with chronic pain and fever episodes, persistent under-treatment, health inequities, and structural factors accelerating both types of disorders-are driving sustained and increasing consumption of over-the-counter antipyretic/analgesics such as paracetamol. As chronic pain sufferers often rely on OTC relief in the absence of specialist care, and fever conditions frequently prompt immediate symptomatic treatment, paracetamol remains a first-line, low-cost, widely accessible option. Manufacturers respond by widening availability, emphasizing safety messaging, and incorporating paracetamol into a broader range of combination therapies.

The comparative company analysis evaluates and categorizes the paracetamol market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global paracetamol market. The key market players are Mallinckrodt Plc, GSK Plc, Johnson & Johnson, Sanofi SA, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr. Reddy's Laboratories Ltd, Granules India Ltd, and IOL Chemicals and Pharmaceuticals Ltd

Based on dosage form, the paracetamol market is segmented into tablets, capsules, and others. In 2024, the tablets segment held a significant paracetamol market share.

By indication, the market is categorized into mild and moderate pain, fever and others. The mild and moderate pain segment accounted for the largest share of the paracetamol market in 2024. Paracetamol remains a globally recommended first-line therapy for mild to moderate pain, including headaches, muscle aches, menstrual discomfort, dental pain, and postoperative soreness. Its popularity stems from a central analgesic mechanism, low gastrointestinal side effects, and long-standing over-the-counter (OTC) availability. These attributes make it suitable for a wide range of populations, including the elderly, pregnant women, and pediatric patients. Clinical evidence supports that doses between 500 mg and 1 g four-hourly (maximum 4 g/day) effectively relieve many acute pain episodes. Recent safety literature, The Sun UK Edition, a media report, (2024) continues to question routine use in older populations, linking long-term use to increased risks, including peptic ulcer bleeding (+24%), lower GI bleeding (+36%), and heart failure risk (+9%) among adults aged 65+, raising concerns about the risks associated with prolonged or high-frequency dosing. Usage patterns shifted significantly during the COVID-19 era, with demand surging-many countries saw a multi-fold increase in self-medication for fever and general aches, reinforcing paracetamol's position as a staple analgesic. Globally, the rising burden of chronic pain conditions-headaches, arthritis, back pain, and migraines-has fueled ongoing high usage, while self-medication and expanding e-pharmacy models in markets such as North America, Asia Pacific, and Latin America further broaden OTC paracetamol access.

Based on route of administration, the paracetamol market is segmented into enteral and parenteral. The enteral segment held the largest share of the market in 2024, owing to the higher accepted route of administrations of paracetamol for disease treatment.

Regarding distribution channel, the paracetamol market is categorized into retail pharmacies, hospital pharmacies and online pharmacies. The retail pharmacies segment held the largest share of the paracetamol market in 2024 due to the high dependency of patients on retail pharmacies for the medications.

Companies operating in the paracetamol market adopt various organic and inorganic strategies. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses, enhance their geographic presence, and contribute to the overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few significant developments by key paracetamol market players are listed below.

In August 2025, Teva Pharmaceutical Industries said it will stop producing its widely used painkiller Acamol in Israel and move manufacturing to its facility in Ulm, Germany. The company said relocating production from its Kfar Saba plant employing around 1,000 workers is part of a broader global strategy to streamline operations and align Israeli products with European standards. Versions of the drug, such as Acamol Focus, Acamol Cold in gel capsules, and Acamol Forte, will continue to be produced in Israel.

In October 2024, Sanofi announces that it has negotiated with CD&R to potentially sell a 50% controlling stake in Opella, its consumer healthcare business. Any agreement would be subject to the completion of the necessary social processes. Further updates on the potential separation of Opella will be provided when a decision is made.

In October 2024, CFAO has acquired Opella Healthcare South Africa. This partnership will only include Sanofi's consumer healthcare brands. Sanofi's pharmaceutical medicines and vaccines will still operate separately in South Africa.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Paracetamol Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Paracetamol Market - Key Market Dynamics

  • 5.1 Paracetamol Market - Key Market Dynamics
  • 5.2 Key Market Drivers
    • 5.2.1 Rise in Prevalence of Chronic Pain and Fever-Related Disorders
    • 5.2.2 Wide Usage of Paracetamol as Over-the-Counter (OTC) Analgesic and Antipyretic
  • 5.3 Key Market Restraints
    • 5.3.1 Raw Material Supply Dependency and Price Volatility
  • 5.4 Key Market Opportunities
    • 5.4.1 Growing Demand for Intravenous (IV) Paracetamol in Clinical Settings
  • 5.5 Key Future Trends
    • 5.5.1 Expansion of Paracetamol Combination Therapy Products
  • 5.6 Impact of Drivers and Restraints:

6. Paracetamol Market - Global Market Analysis

  • 6.1 Paracetamol Market Revenue (US$ Million), 2021-2031
  • 6.2 Paracetamol Market Forecast Analysis

7. Paracetamol Market Analysis - by Dosage Form

  • 7.1 Tablet
    • 7.1.1 Overview
    • 7.1.2 Tablet: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Capsule
    • 7.2.1 Overview
    • 7.2.2 Capsule: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Others
    • 7.3.1 Overview
    • 7.3.2 Others: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)

8. Paracetamol Market Analysis - by Indication

  • 8.1 Mild and Moderate Pain
    • 8.1.1 Overview
    • 8.1.2 Mild and Moderate Pain: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Fever
    • 8.2.1 Overview
    • 8.2.2 Fever: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)

9. Paracetamol Market Analysis - by Route Of Administration

  • 9.1 Enteral
    • 9.1.1 Overview
    • 9.1.2 Enteral: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Parenteral
    • 9.2.1 Overview
    • 9.2.2 Parenteral: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)

10. Paracetamol Market Analysis - by Distribution Channel

  • 10.1 Retail Pharmacies
    • 10.1.1 Overview
    • 10.1.2 Retail Pharmacies: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Hospital Pharmacies
    • 10.2.1 Overview
    • 10.2.2 Hospital Pharmacies: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Online Pharmacies
    • 10.3.1 Overview
    • 10.3.2 Online Pharmacies: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)

11. Paracetamol Market - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Paracetamol Market Overview
    • 11.1.2 North America: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
      • 11.1.2.1 North America: Paracetamol Market - Revenue and Forecast Analysis - by Dosage Form
      • 11.1.2.2 North America: Paracetamol Market - Revenue and Forecast Analysis - by Indication
      • 11.1.2.3 North America: Paracetamol Market - Revenue and Forecast Analysis - by Route Of Administration
      • 11.1.2.4 North America: Paracetamol Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.1.3 North America: Paracetamol Market - Revenue and Forecast Analysis - by Country
      • 11.1.3.1 United States: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.3.1.1 United States: Paracetamol Market Breakdown, by Dosage Form
        • 11.1.3.1.2 United States: Paracetamol Market Breakdown, by Indication
        • 11.1.3.1.3 United States: Paracetamol Market Breakdown, by Route Of Administration
        • 11.1.3.1.4 United States: Paracetamol Market Breakdown, by Distribution Channel
      • 11.1.3.2 Canada: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.3.2.1 Canada: Paracetamol Market Breakdown, by Dosage Form
        • 11.1.3.2.2 Canada: Paracetamol Market Breakdown, by Indication
        • 11.1.3.2.3 Canada: Paracetamol Market Breakdown, by Route Of Administration
        • 11.1.3.2.4 Canada: Paracetamol Market Breakdown, by Distribution Channel
      • 11.1.3.3 Mexico: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.3.3.1 Mexico: Paracetamol Market Breakdown, by Dosage Form
        • 11.1.3.3.2 Mexico: Paracetamol Market Breakdown, by Indication
        • 11.1.3.3.3 Mexico: Paracetamol Market Breakdown, by Route Of Administration
        • 11.1.3.3.4 Mexico: Paracetamol Market Breakdown, by Distribution Channel
  • 11.2 Europe
    • 11.2.1 Europe Paracetamol Market Overview
    • 11.2.2 Europe: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
      • 11.2.2.1 Europe: Paracetamol Market - Revenue and Forecast Analysis - by Dosage Form
      • 11.2.2.2 Europe: Paracetamol Market - Revenue and Forecast Analysis - by Indication
      • 11.2.2.3 Europe: Paracetamol Market - Revenue and Forecast Analysis - by Route Of Administration
      • 11.2.2.4 Europe: Paracetamol Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.2.3 Europe: Paracetamol Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 Germany: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.1.1 Germany: Paracetamol Market Breakdown, by Dosage Form
        • 11.2.3.1.2 Germany: Paracetamol Market Breakdown, by Indication
        • 11.2.3.1.3 Germany: Paracetamol Market Breakdown, by Route Of Administration
        • 11.2.3.1.4 Germany: Paracetamol Market Breakdown, by Distribution Channel
      • 11.2.3.2 United Kingdom: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.2.1 United Kingdom: Paracetamol Market Breakdown, by Dosage Form
        • 11.2.3.2.2 United Kingdom: Paracetamol Market Breakdown, by Indication
        • 11.2.3.2.3 United Kingdom: Paracetamol Market Breakdown, by Route Of Administration
        • 11.2.3.2.4 United Kingdom: Paracetamol Market Breakdown, by Distribution Channel
      • 11.2.3.3 France: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.3.1 France: Paracetamol Market Breakdown, by Dosage Form
        • 11.2.3.3.2 France: Paracetamol Market Breakdown, by Indication
        • 11.2.3.3.3 France: Paracetamol Market Breakdown, by Route Of Administration
        • 11.2.3.3.4 France: Paracetamol Market Breakdown, by Distribution Channel
      • 11.2.3.4 Italy: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.4.1 Italy: Paracetamol Market Breakdown, by Dosage Form
        • 11.2.3.4.2 Italy: Paracetamol Market Breakdown, by Indication
        • 11.2.3.4.3 Italy: Paracetamol Market Breakdown, by Route Of Administration
        • 11.2.3.4.4 Italy: Paracetamol Market Breakdown, by Distribution Channel
      • 11.2.3.5 Spain: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.5.1 Spain: Paracetamol Market Breakdown, by Dosage Form
        • 11.2.3.5.2 Spain: Paracetamol Market Breakdown, by Indication
        • 11.2.3.5.3 Spain: Paracetamol Market Breakdown, by Route Of Administration
        • 11.2.3.5.4 Spain: Paracetamol Market Breakdown, by Distribution Channel
      • 11.2.3.6 Rest of Europe: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.6.1 Rest of Europe: Paracetamol Market Breakdown, by Dosage Form
        • 11.2.3.6.2 Rest of Europe: Paracetamol Market Breakdown, by Indication
        • 11.2.3.6.3 Rest of Europe: Paracetamol Market Breakdown, by Route Of Administration
        • 11.2.3.6.4 Rest of Europe: Paracetamol Market Breakdown, by Distribution Channel
  • 11.3 Asia Pacific
    • 11.3.1 Asia Pacific Paracetamol Market Overview
    • 11.3.2 Asia Pacific: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
      • 11.3.2.1 Asia Pacific: Paracetamol Market - Revenue and Forecast Analysis - by Dosage Form
      • 11.3.2.2 Asia Pacific: Paracetamol Market - Revenue and Forecast Analysis - by Indication
      • 11.3.2.3 Asia Pacific: Paracetamol Market - Revenue and Forecast Analysis - by Route Of Administration
      • 11.3.2.4 Asia Pacific: Paracetamol Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.3.3 Asia Pacific: Paracetamol Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 China: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.1.1 China: Paracetamol Market Breakdown, by Dosage Form
        • 11.3.3.1.2 China: Paracetamol Market Breakdown, by Indication
        • 11.3.3.1.3 China: Paracetamol Market Breakdown, by Route Of Administration
        • 11.3.3.1.4 China: Paracetamol Market Breakdown, by Distribution Channel
      • 11.3.3.2 Japan: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.2.1 Japan: Paracetamol Market Breakdown, by Dosage Form
        • 11.3.3.2.2 Japan: Paracetamol Market Breakdown, by Indication
        • 11.3.3.2.3 Japan: Paracetamol Market Breakdown, by Route Of Administration
        • 11.3.3.2.4 Japan: Paracetamol Market Breakdown, by Distribution Channel
      • 11.3.3.3 India: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.3.1 India: Paracetamol Market Breakdown, by Dosage Form
        • 11.3.3.3.2 India: Paracetamol Market Breakdown, by Indication
        • 11.3.3.3.3 India: Paracetamol Market Breakdown, by Route Of Administration
        • 11.3.3.3.4 India: Paracetamol Market Breakdown, by Distribution Channel
      • 11.3.3.4 Australia: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.4.1 Australia: Paracetamol Market Breakdown, by Dosage Form
        • 11.3.3.4.2 Australia: Paracetamol Market Breakdown, by Indication
        • 11.3.3.4.3 Australia: Paracetamol Market Breakdown, by Route Of Administration
        • 11.3.3.4.4 Australia: Paracetamol Market Breakdown, by Distribution Channel
      • 11.3.3.5 South Korea: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.5.1 South Korea: Paracetamol Market Breakdown, by Dosage Form
        • 11.3.3.5.2 South Korea: Paracetamol Market Breakdown, by Indication
        • 11.3.3.5.3 South Korea: Paracetamol Market Breakdown, by Route Of Administration
        • 11.3.3.5.4 South Korea: Paracetamol Market Breakdown, by Distribution Channel
      • 11.3.3.6 Rest of APAC: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.6.1 Rest of APAC: Paracetamol Market Breakdown, by Dosage Form
        • 11.3.3.6.2 Rest of APAC: Paracetamol Market Breakdown, by Indication
        • 11.3.3.6.3 Rest of APAC: Paracetamol Market Breakdown, by Route Of Administration
        • 11.3.3.6.4 Rest of APAC: Paracetamol Market Breakdown, by Distribution Channel
  • 11.4 Middle East and Africa
    • 11.4.1 Middle East and Africa Paracetamol Market Overview
    • 11.4.2 Middle East and Africa: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
      • 11.4.2.1 Middle East and Africa: Paracetamol Market - Revenue and Forecast Analysis - by Dosage Form
      • 11.4.2.2 Middle East and Africa: Paracetamol Market - Revenue and Forecast Analysis - by Indication
      • 11.4.2.3 Middle East and Africa: Paracetamol Market - Revenue and Forecast Analysis - by Route Of Administration
      • 11.4.2.4 Middle East and Africa: Paracetamol Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.4.3 Middle East and Africa: Paracetamol Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Saudi Arabia: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.1.1 Saudi Arabia: Paracetamol Market Breakdown, by Dosage Form
        • 11.4.3.1.2 Saudi Arabia: Paracetamol Market Breakdown, by Indication
        • 11.4.3.1.3 Saudi Arabia: Paracetamol Market Breakdown, by Route Of Administration
        • 11.4.3.1.4 Saudi Arabia: Paracetamol Market Breakdown, by Distribution Channel
      • 11.4.3.2 South Africa: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.2.1 South Africa: Paracetamol Market Breakdown, by Dosage Form
        • 11.4.3.2.2 South Africa: Paracetamol Market Breakdown, by Indication
        • 11.4.3.2.3 South Africa: Paracetamol Market Breakdown, by Route Of Administration
        • 11.4.3.2.4 South Africa: Paracetamol Market Breakdown, by Distribution Channel
      • 11.4.3.3 United Arab Emirates: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.3.1 United Arab Emirates: Paracetamol Market Breakdown, by Dosage Form
        • 11.4.3.3.2 United Arab Emirates: Paracetamol Market Breakdown, by Indication
        • 11.4.3.3.3 United Arab Emirates: Paracetamol Market Breakdown, by Route Of Administration
        • 11.4.3.3.4 United Arab Emirates: Paracetamol Market Breakdown, by Distribution Channel
      • 11.4.3.4 Rest of Middle East and Africa: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.4.1 Rest of Middle East and Africa: Paracetamol Market Breakdown, by Dosage Form
        • 11.4.3.4.2 Rest of Middle East and Africa: Paracetamol Market Breakdown, by Indication
        • 11.4.3.4.3 Rest of Middle East and Africa: Paracetamol Market Breakdown, by Route Of Administration
        • 11.4.3.4.4 Rest of Middle East and Africa: Paracetamol Market Breakdown, by Distribution Channel
  • 11.5 South and Central America
    • 11.5.1 South and Central America Paracetamol Market Overview
    • 11.5.2 South and Central America: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
      • 11.5.2.1 South and Central America: Paracetamol Market - Revenue and Forecast Analysis - by Dosage Form
      • 11.5.2.2 South and Central America: Paracetamol Market - Revenue and Forecast Analysis - by Indication
      • 11.5.2.3 South and Central America: Paracetamol Market - Revenue and Forecast Analysis - by Route Of Administration
      • 11.5.2.4 South and Central America: Paracetamol Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.5.3 South and Central America: Paracetamol Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Brazil: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.3.1.1 Brazil: Paracetamol Market Breakdown, by Dosage Form
        • 11.5.3.1.2 Brazil: Paracetamol Market Breakdown, by Indication
        • 11.5.3.1.3 Brazil: Paracetamol Market Breakdown, by Route Of Administration
        • 11.5.3.1.4 Brazil: Paracetamol Market Breakdown, by Distribution Channel
      • 11.5.3.2 Argentina: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.3.2.1 Argentina: Paracetamol Market Breakdown, by Dosage Form
        • 11.5.3.2.2 Argentina: Paracetamol Market Breakdown, by Indication
        • 11.5.3.2.3 Argentina: Paracetamol Market Breakdown, by Route Of Administration
        • 11.5.3.2.4 Argentina: Paracetamol Market Breakdown, by Distribution Channel
      • 11.5.3.3 Rest of South and Central America: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.3.3.1 Rest of South and Central America: Paracetamol Market Breakdown, by Dosage Form
        • 11.5.3.3.2 Rest of South and Central America: Paracetamol Market Breakdown, by Indication
        • 11.5.3.3.3 Rest of South and Central America: Paracetamol Market Breakdown, by Route Of Administration
        • 11.5.3.3.4 Rest of South and Central America: Paracetamol Market Breakdown, by Distribution Channel

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning & Concentration

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Expansions And Other Strategic Developments

14. Company Profiles

  • 14.1 Mallinckrodt Plc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 GSK Plc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Johnson & Johnson
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Sanofi SA
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Teva Pharmaceutical Industries Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Sun Pharmaceutical Industries Ltd
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Cipla Ltd
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Dr. Reddy's Laboratories Ltd
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Financial Overview
    • 14.8.4 SWOT Analysis
    • 14.8.5 Key Developments
  • 14.9 Granules India Ltd
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 IOL Chemicals and Pharmaceuticals Ltd.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Paracetamol Market Segmentation
  • Table 2. North America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 3. North America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 4. North America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 5. North America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 6. North America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 7. North America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 8. North America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 9. North America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 10. United States: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 11. United States: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 12. United States: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 13. United States: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 14. United States: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 15. United States: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 16. United States: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 17. United States: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 18. Canada: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 19. Canada: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 20. Canada: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 21. Canada: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 22. Canada: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 23. Canada: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 24. Canada: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 25. Canada: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 26. Mexico: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 27. Mexico: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 28. Mexico: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 29. Mexico: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 30. Mexico: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 31. Mexico: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 32. Mexico: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 33. Mexico: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 34. Europe: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 35. Europe: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 36. Europe: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 37. Europe: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 38. Europe: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 39. Europe: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 40. Europe: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 41. Europe: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 42. Germany: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 43. Germany: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 44. Germany: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 45. Germany: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 46. Germany: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 47. Germany: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 48. Germany: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 49. Germany: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 50. United Kingdom: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 51. United Kingdom: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 52. United Kingdom: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 53. United Kingdom: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 54. United Kingdom: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 55. United Kingdom: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 56. United Kingdom: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 57. United Kingdom: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 58. France: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 59. France: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 60. France: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 61. France: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 62. France: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 63. France: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 64. France: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 65. France: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 66. Italy: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 67. Italy: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 68. Italy: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 69. Italy: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 70. Italy: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 71. Italy: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 72. Italy: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 73. Italy: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 74. Spain: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 75. Spain: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 76. Spain: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 77. Spain: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 78. Spain: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 79. Spain: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 80. Spain: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 81. Spain: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 82. Rest of Europe: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 83. Rest of Europe: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 84. Rest of Europe: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 85. Rest of Europe: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 86. Rest of Europe: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 87. Rest of Europe: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 88. Rest of Europe: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 89. Rest of Europe: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 90. Asia Pacific: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 91. Asia Pacific: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 92. Asia Pacific: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 93. Asia Pacific: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 94. Asia Pacific: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 95. Asia Pacific: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 96. Asia Pacific: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 97. Asia Pacific: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 98. China: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 99. China: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 100. China: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 101. China: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 102. China: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 103. China: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 104. China: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 105. China: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 106. Japan: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 107. Japan: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 108. Japan: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 109. Japan: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 110. Japan: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 111. Japan: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 112. Japan: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 113. Japan: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 114. India: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 115. India: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 116. India: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 117. India: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 118. India: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 119. India: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 120. India: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 121. India: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 122. Australia: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 123. Australia: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 124. Australia: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 125. Australia: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 126. Australia: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 127. Australia: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 128. Australia: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 129. Australia: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 130. South Korea: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 131. South Korea: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 132. South Korea: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 133. South Korea: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 134. South Korea: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 135. South Korea: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 136. South Korea: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 137. South Korea: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 138. Rest of APAC: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 139. Rest of APAC: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 140. Rest of APAC: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 141. Rest of APAC: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 142. Rest of APAC: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 143. Rest of APAC: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 144. Rest of APAC: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 145. Rest of APAC: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 146. Middle East and Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 147. Middle East and Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 148. Middle East and Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 149. Middle East and Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 150. Middle East and Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 151. Middle East and Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 152. Middle East and Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 153. Middle East and Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 154. Saudi Arabia: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 155. Saudi Arabia: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 156. Saudi Arabia: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 157. Saudi Arabia: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 158. Saudi Arabia: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 159. Saudi Arabia: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 160. Saudi Arabia: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 161. Saudi Arabia: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 162. South Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 163. South Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 164. South Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 165. South Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 166. South Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 167. South Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 168. South Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 169. South Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 170. United Arab Emirates: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 171. United Arab Emirates: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 172. United Arab Emirates: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 173. United Arab Emirates: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 174. United Arab Emirates: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 175. United Arab Emirates: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 176. United Arab Emirates: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 177. United Arab Emirates: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 178. Rest of Middle East and Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 179. Rest of Middle East and Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 180. Rest of Middle East and Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 181. Rest of Middle East and Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 182. Rest of Middle East and Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 183. Rest of Middle East and Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 184. Rest of Middle East and Africa: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 185. Rest of Middle East and Africa: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 186. South and Central America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 187. South and Central America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 188. South and Central America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 189. South and Central America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 190. South and Central America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 191. South and Central America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 192. South and Central America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 193. South and Central America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 194. Brazil: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 195. Brazil: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 196. Brazil: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 197. Brazil: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 198. Brazil: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 199. Brazil: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 200. Brazil: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 201. Brazil: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 202. Argentina: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 203. Argentina: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 204. Argentina: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 205. Argentina: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 206. Argentina: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 207. Argentina: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 208. Argentina: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 209. Argentina: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 210. Rest of South and Central America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Dosage Form
  • Table 211. Rest of South and Central America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Dosage Form
  • Table 212. Rest of South and Central America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 213. Rest of South and Central America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 214. Rest of South and Central America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 215. Rest of South and Central America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 216. Rest of South and Central America: Paracetamol Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 217. Rest of South and Central America: Paracetamol Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 218. Heat Map Analysis by Key Players
  • Table 219. Glossary of Terms, Paracetamol Market

List Of Figures

  • Figure 1. Paracetamol Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Paracetamol Market Revenue (US$ Million), 2021-2031
  • Figure 5. Paracetamol Market Forecast Analysis
  • Figure 6. Paracetamol Market Share (%) - by Dosage Form (2024 and 2031)
  • Figure 7. Tablet: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Capsule: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Others: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Paracetamol Market Share (%) - by Indication (2024 and 2031)
  • Figure 11. Mild and Moderate Pain: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Fever: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Others: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Paracetamol Market Share (%) - by Route Of Administration (2024 and 2031)
  • Figure 15. Enteral: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Parenteral: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Paracetamol Market Share (%) - by Distribution Channel (2024 and 2031)
  • Figure 18. Retail Pharmacies: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Hospital Pharmacies: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Online Pharmacies: Paracetamol Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. North America: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
  • Figure 22. North America: Paracetamol Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 23. United States: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Canada: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Mexico: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Europe: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
  • Figure 27. Europe: Paracetamol Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 28. Germany: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 29. United Kingdom: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. France: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Italy: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. Spain: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Rest of Europe: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Asia Pacific: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
  • Figure 35. Asia Pacific: Paracetamol Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 36. China: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Japan: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. India: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 39. Australia: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. South Korea: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Rest of APAC: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. Middle East and Africa: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
  • Figure 43. Middle East and Africa: Paracetamol Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 44. Saudi Arabia: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 45. South Africa: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. United Arab Emirates: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. Rest of Middle East and Africa: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. South and Central America: Paracetamol Market - Revenue, 2021-2031 (US$ Million)
  • Figure 49. South and Central America: Paracetamol Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 50. Brazil: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 51. Argentina: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 52. Rest of South and Central America: Paracetamol Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 53. Company Positioning & Concentration